EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals Inc.
WKN: A2QJRU / Symbol: EYPT / Name: EyePoint Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
11,02 €
-7,43 %
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Mizuho from $30.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target raised by analysts at HC Wainwright from $22.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $27.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $39.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Ratings data for EYPT provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in adidas AG ADR diskutieren